SS-31vsThymosin Beta-4

SS-31 (elamipretide, D-Arg-Dmt-Lys-Phe-NH2) is a cell-permeable, mitochondria-targeted tetrapeptide with an alternating aromatic-cationic motif that drives its remarkable 1,000-fold concentration within mitochondria. This accumulation is driven by the highly negative mitochondrial membrane potential (-180 mV), which electrostatically attracts the cationic peptide, and by its lipophilic aromatic residues which partition into the inner mitochondrial membrane.

Once concentrated in the inner mitochondrial membrane, SS-31 selectively binds to cardiolipin — a unique dimeric phospholipid found almost exclusively in this membrane. Cardiolipin plays an essential structural role: it anchors cytochrome c to the inner membrane surface, optimizing electron transfer between Complex III and Complex IV of the electron transport chain (ETC). With aging and disease, cardiolipin undergoes peroxidation by reactive oxygen species (ROS), which disrupts its interaction with cytochrome c. Loosened cytochrome c transfers electrons less efficiently, increasing electron leak to molecular oxygen and generating more ROS — creating a vicious cycle of mitochondrial decline.

SS-31 breaks this cycle by stabilizing the cardiolipin-cytochrome c interaction, restoring optimal electron transfer efficiency and reducing ROS generation at the source. It also protects cardiolipin from peroxidation by ROS scavenging through its dimethyltyrosine (Dmt) residue. The downstream effects are profound: restored mitochondrial membrane potential, improved ATP production, reduced oxidative damage to mitochondrial DNA and proteins, and prevention of the mitochondrial permeability transition pore (mPTP) opening that triggers apoptosis. In aged tissues, where mitochondrial dysfunction is a hallmark of cellular decline, SS-31 effectively rejuvenates mitochondrial function toward a younger phenotype. Clinical studies have shown improvements in skeletal muscle energetics, cardiac function, and exercise tolerance in elderly subjects and patients with mitochondrial myopathy.

Thymosin Beta-4 (Tβ4) is a 43-amino-acid peptide and the most abundant member of the beta-thymosin family. Despite its name (derived from its original isolation from thymus tissue), Tβ4 is expressed in virtually every nucleated cell in the body and is particularly concentrated in platelets, wound fluid, and developing tissues. TB-500 is the commercially available active fragment.

The primary molecular function is G-actin sequestration. Tβ4 binds globular actin (G-actin) monomers at a 1:1 stoichiometric ratio through a central actin-binding domain (LKKTET motif), maintaining a large intracellular pool of unpolymerized actin available for rapid mobilization. When cells need to migrate — as during wound healing, inflammation, or development — Tβ4 releases G-actin for polymerization into filamentous actin (F-actin) at the cell's leading edge. This dynamic actin cycling is the fundamental force-generating mechanism for cell migration.

Beyond actin regulation, Tβ4 has extensive signaling functions. It promotes angiogenesis by stimulating endothelial cell migration, tubule formation, and the expression of VEGF and angiopoietin-1. It reduces inflammation by modulating NF-κB signaling, decreasing production of TNF-α, IL-1β, and other pro-inflammatory mediators. In wound healing, Tβ4 upregulates laminin-5 production — a key component of the basement membrane that guides epithelial cell migration during wound re-epithelialization. It activates cardiac progenitor cells and promotes cardiomyocyte survival following ischemic injury, an effect that has generated significant interest for cardiac repair applications.

Tβ4 also promotes stem cell migration and differentiation through activation of the Akt cell survival pathway. It stimulates hair follicle stem cell migration and differentiation, which has been observed as increased hair growth in animal studies. The combination of cell migration, angiogenesis, anti-inflammation, stem cell activation, and extracellular matrix remodeling makes Tβ4 one of the most comprehensive endogenous healing molecules identified.